A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group
JM Melse, ML Essink-Bot, PG Kramers and N Hoeymans
Department for Public Health Forecasting, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
OBJECTIVES: This study estimated the burden of disease due to 48 major
causes in the Netherlands in 1994 in disability-adjusted life-years
(DALYs), using national epidemiologic data and disability weights, and
explored associated problems and uncertainties. METHODS: We combined data
from Dutch vital statistics, registrations, and surveys with Dutch
disability weights to calculate disease-specific health loss in DALYs,
which are the sum of years of life lost (YLLs) and years lived with
disability (YLDs) weighted for severity. RESULTS: YLLs were primarily lost
by cardiovascular diseases and cancers, while YLDs were mostly lost by
mental disorders and a range of chronic somatic disorders (such as chronic
nonspecific lung disease and diabetes). These 4 diagnostic groups caused
approximately equal numbers of DALYs. Sensitivity analysis calls for
improving the accuracy of the epidemiologic data in connection with
disability weights, especially for mild and frequent diseases. CONCLUSIONS:
The DALY approach appeared to be feasible at a national Western European
level and produced interpretable results, comparable to results from the
Global Burden of Disease Study for the Established Market Economies.
Suggestions for improving the methodology and its applicability are
presented.
This article has been cited by other articles:
T. Lai, J. Habicht, and R.-A. Kiivet Measuring burden of disease in Estonia to support public health policy
Eur J Public Health,
October 1, 2009;
19(5):
541 - 547.
[Abstract][Full Text][PDF]
C. Terschuren, O. C. L. Mekel, R. Samson, T. K. D. Classen, C. Hornberg, and R. Fehr Health status of 'Ruhr-City' in 2025 - predicted disease burden for the metropolitan Ruhr area in North Rhine-Westphalia
Eur J Public Health,
October 1, 2009;
19(5):
534 - 540.
[Abstract][Full Text][PDF]
H. Dodhia and K. Phillips Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years
J. Public Health Med.,
September 1, 2008;
30(3):
313 - 321.
[Abstract][Full Text][PDF]
A. Lapostolle, A. Lefranc, I. Gremy, and A. Spira Sensitivity analysis in summary measure of population health in France
Eur J Public Health,
April 1, 2008;
18(2):
195 - 200.
[Abstract][Full Text][PDF]
S. I. SAARNI, J. SUVISAARI, H. SINTONEN, S. PIRKOLA, S. KOSKINEN, A. AROMAA, and J. LONNQVIST Impact of psychiatric disorders on health-related quality of life: general population survey
The British Journal of Psychiatry,
April 1, 2007;
190(4):
326 - 332.
[Abstract][Full Text][PDF]
M. A.M. Jacobs-van der Bruggen, G. Bos, W. J. Bemelmans, R. T. Hoogenveen, S. M. Vijgen, and C. A. Baan Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk: Results from a modeling study
Diabetes Care,
January 1, 2007;
30(1):
128 - 134.
[Abstract][Full Text][PDF]
J. George, T. Vuong, M. J Bailey, D. C. Kong, J. L Marriott, and K. Stewart Development and Validation of the Medication-Based Disease Burden Index
Ann. Pharmacother.,
April 1, 2006;
40(4):
645 - 650.
[Abstract][Full Text][PDF]
M. M. Ortegon, W. K. Redekop, and L. W. Niessen Cost-Effectiveness of Prevention and Treatment of the Diabetic Foot: A Markov analysis
Diabetes Care,
April 1, 2004;
27(4):
901 - 907.
[Abstract][Full Text][PDF]
G. ANDREWS, K. SANDERSON, J. CORRY, C. ISSAKIDIS, and H. LAPSLEY Cost-effectiveness of current and optimal treatment for schizophrenia
The British Journal of Psychiatry,
November 1, 2003;
183(5):
427 - 435.
[Abstract][Full Text][PDF]
D G Manuel, S E Schultz, and J A Kopec Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities Index
J Epidemiol Community Health,
November 1, 2002;
56(11):
843 - 850.
[Abstract][Full Text][PDF]